Your browser doesn't support javascript.
loading
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.
Voso, Maria-Teresa; Pandzic, Tatjana; Falconi, Giulia; Dencic-Fekete, Marija; De Bellis, Eleonora; Scarfo, Lydia; Ljungström, Viktor; Iskas, Michail; Del Poeta, Giovanni; Ranghetti, Pamela; Laidou, Stamatia; Cristiano, Antonio; Plevova, Karla; Imbergamo, Silvia; Engvall, Marie; Zucchetto, Antonella; Salvetti, Chiara; Mauro, Francesca R; Stavroyianni, Niki; Cavelier, Lucia; Ghia, Paolo; Stamatopoulos, Kostas; Fabiani, Emiliano; Baliakas, Panagiotis.
Afiliação
  • Voso MT; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Pandzic T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Falconi G; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.
  • Dencic-Fekete M; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • De Bellis E; Clinic for Hematology, Clinical Center of Serbia, Belgrade, Serbia.
  • Scarfo L; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Ljungström V; Strategic Research Programme in CLL, Division of Experimental Oncology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
  • Iskas M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Del Poeta G; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.
  • Ranghetti P; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Laidou S; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Cristiano A; Strategic Research Programme in CLL, Division of Experimental Oncology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
  • Plevova K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Imbergamo S; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Engvall M; Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Zucchetto A; Department of Internal Medicine - Haematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Salvetti C; Hematology and Clinical Immunology, Department of Hematology, Hospital of Padua, Padua, Italy.
  • Mauro FR; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Stavroyianni N; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.
  • Cavelier L; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Ghia P; Division of Hematology, University of Turin, Turin, Italy.
  • Stamatopoulos K; Department of Translational and Precision Medicine, Hematology, 'Sapienza' University, Rome, Italy.
  • Fabiani E; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Br J Haematol ; 198(1): 103-113, 2022 07.
Article em En | MEDLINE | ID: mdl-35277855
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Segunda Neoplasia Primária Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Segunda Neoplasia Primária Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália